Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Morantel
2. Paratect
3. Tartrate, Morantel
1. Morantel Tartrate Salt
2. 26155-31-7
3. Mls000069820
4. 26155-31-7 (tartrate)
5. Smr000058831
6. Suiminth
7. (e)-1-methyl-2-(2-(3-methylthiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine 2,3-dihydroxysuccinate
8. Morantel (tartrate)
9. Morantel (+)-tartrate Salt
10. Nsc-758647
11. Prestwick_508
12. Cp-12009-18
13. Cp-12-009-18
14. Opera_id_226
15. Prestwick2_000061
16. Prestwick3_000061
17. Bspbio_000241
18. Mls001148663
19. Schembl117920
20. Bpbio1_000267
21. Chembl1445794
22. Amy3560
23. Ex-a929
24. Hms1568m03
25. Hms2095m03
26. Hms2234o05
27. Hms3712m03
28. Bba15531
29. Mfcd00079449
30. Ccg-220061
31. Ac-32488
32. 155m317
33. J-016285
34. Sr-01000721901-4
Molecular Weight | 370.4 g/mol |
---|---|
Molecular Formula | C16H22N2O6S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 370.11985760 g/mol |
Monoisotopic Mass | 370.11985760 g/mol |
Topological Polar Surface Area | 159 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 407 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
Anthelmintics
Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Morantel Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Morantel Tartrate, including repackagers and relabelers. The FDA regulates Morantel Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Morantel Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Morantel Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Morantel Tartrate supplier is an individual or a company that provides Morantel Tartrate active pharmaceutical ingredient (API) or Morantel Tartrate finished formulations upon request. The Morantel Tartrate suppliers may include Morantel Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Morantel Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Morantel Tartrate written confirmation (Morantel Tartrate WC) is an official document issued by a regulatory agency to a Morantel Tartrate manufacturer, verifying that the manufacturing facility of a Morantel Tartrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Morantel Tartrate APIs or Morantel Tartrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Morantel Tartrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Morantel Tartrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Morantel Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Morantel Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Morantel Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Morantel Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Morantel Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Morantel Tartrate suppliers with NDC on PharmaCompass.
Morantel Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Morantel Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Morantel Tartrate GMP manufacturer or Morantel Tartrate GMP API supplier for your needs.
A Morantel Tartrate CoA (Certificate of Analysis) is a formal document that attests to Morantel Tartrate's compliance with Morantel Tartrate specifications and serves as a tool for batch-level quality control.
Morantel Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Morantel Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Morantel Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Morantel Tartrate EP), Morantel Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Morantel Tartrate USP).
LOOKING FOR A SUPPLIER?